The market for palliative care for rare cancers is witnessing notable growth as the understanding and awareness of these unique and often aggressive diseases increase. The market is driven by the rising incidence of rare cancers and the recognition of the significant unmet needs of patients facing these conditions. Palliative care services that focus on symptom management, psychosocial support, and end-of-life care are in high demand. The integration of palliative care into the treatment plans for rare cancers is gaining prominence. However, challenges such as limited research and clinical guidelines, variations in access to specialized care, and the need for multidisciplinary collaboration persist. The market for palliative care for rare cancers is expected to continue expanding as healthcare systems strive to improve the quality of life and support for individuals facing these challenging diseases.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
